BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,844,213 | +153.1% | 542,968 | +151.7% | 0.01% | +150.0% |
| Q2 2023 | $1,518,824 | -46.5% | 215,742 | -36.6% | 0.00% | -50.0% |
| Q1 2023 | $2,838,861 | +57.9% | 340,391 | +117.4% | 0.00% | +33.3% |
| Q4 2022 | $1,797,458 | -99.9% | 156,573 | -34.7% | 0.00% | -40.0% |
| Q3 2022 | $3,022,488,000 | +602.2% | 239,880 | +489.6% | 0.01% | +400.0% |
| Q2 2022 | $430,416,000 | +2.4% | 40,682 | +57.4% | 0.00% | 0.0% |
| Q1 2022 | $420,240,000 | -53.9% | 25,845 | -60.8% | 0.00% | 0.0% |
| Q4 2021 | $912,106,000 | +44.6% | 65,856 | +50.0% | 0.00% | 0.0% |
| Q3 2021 | $630,900,000 | +138.2% | 43,904 | +162.1% | 0.00% | – |
| Q2 2021 | $264,865,000 | -14.7% | 16,753 | -45.2% | 0.00% | – |
| Q1 2021 | $310,673,000 | +122.2% | 30,548 | +62.8% | 0.00% | – |
| Q4 2020 | $139,814,000 | -1.2% | 18,767 | -54.5% | 0.00% | – |
| Q3 2020 | $141,536,000 | -16.9% | 41,204 | +15.3% | 0.00% | – |
| Q2 2020 | $170,287,000 | +20.7% | 35,737 | -49.3% | 0.00% | – |
| Q1 2020 | $141,034,000 | +138.0% | 70,517 | +310.5% | 0.00% | – |
| Q4 2019 | $59,268,000 | +18.5% | 17,179 | -1.6% | 0.00% | – |
| Q3 2019 | $50,017,000 | +7.6% | 17,458 | +42.4% | 0.00% | – |
| Q2 2019 | $46,469,000 | -74.9% | 12,261 | -46.0% | 0.00% | – |
| Q1 2019 | $184,868,000 | +61728.8% | 22,711 | +61281.1% | 0.00% | – |
| Q4 2018 | $299,000 | -98.8% | 37 | -98.9% | 0.00% | – |
| Q3 2018 | $24,851,000 | +33.2% | 3,257 | 0.0% | 0.00% | – |
| Q2 2018 | $18,663,000 | -80.7% | 3,257 | -84.0% | 0.00% | – |
| Q1 2018 | $96,893,000 | -3.5% | 20,313 | -0.7% | 0.00% | – |
| Q4 2017 | $100,439,000 | +131.8% | 20,456 | +147.4% | 0.00% | – |
| Q3 2017 | $43,335,000 | -12.0% | 8,270 | -6.6% | 0.00% | – |
| Q2 2017 | $49,228,000 | +1492.6% | 8,854 | +2306.0% | 0.00% | – |
| Q1 2017 | $3,091,000 | -88.1% | 368 | -91.1% | 0.00% | – |
| Q4 2016 | $26,029,000 | +15.6% | 4,112 | -19.5% | 0.00% | – |
| Q3 2016 | $22,517,000 | +172.3% | 5,106 | +75.3% | 0.00% | – |
| Q2 2016 | $8,270,000 | -94.6% | 2,912 | -80.3% | 0.00% | – |
| Q4 2015 | $152,694,000 | -10.7% | 14,796 | -1.3% | 0.00% | – |
| Q3 2015 | $170,932,000 | +89.8% | 14,994 | +148.5% | 0.00% | – |
| Q2 2015 | $90,073,000 | +504.5% | 6,033 | +265.6% | 0.00% | – |
| Q1 2015 | $14,900,000 | -63.6% | 1,650 | -60.6% | 0.00% | – |
| Q3 2014 | $40,988,000 | – | 4,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |